These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 32193156)

  • 1. PRKN-related familial Parkinson's disease: First molecular confirmation from East Africa.
    Dekker MCJ; Suleiman JM; Bhwana D; Howlett WP; Rashid SM; van Minkelen R; Hamel BC
    Parkinsonism Relat Disord; 2020 Apr; 73():14-15. PubMed ID: 32193156
    [No Abstract]   [Full Text] [Related]  

  • 2. Transcriptional alterations in skin fibroblasts from Parkinson's disease patients with parkin mutations.
    González-Casacuberta I; Morén C; Juárez-Flores DL; Esteve-Codina A; Sierra C; Catalán-García M; Guitart-Mampel M; Tobías E; Milisenda JC; Pont-Sunyer C; Martí MJ; Cardellach F; Tolosa E; Artuch R; Ezquerra M; Fernández-Santiago R; Garrabou G
    Neurobiol Aging; 2018 May; 65():206-216. PubMed ID: 29501959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of evidence for association of Parkin promoter polymorphism (PRKN-258) with increased risk of Parkinson's disease.
    Ross OA; Haugarvoll K; Stone JT; Heckman MG; White LR; Aasly JO; Mark Gibson J; Lynch T; Wszolek ZK; Uitti RJ; Farrer MJ
    Parkinsonism Relat Disord; 2007 Oct; 13(7):386-8. PubMed ID: 17400506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
    Hattori N
    Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Private variants in PRKN are associated with late-onset Parkinson's disease.
    Hopfner F; Mueller SH; Szymczak S; Junge O; Tittmann L; May S; Lohmann K; Grallert H; Lieb W; Strauch K; Müller-Nurasyid M; Berger K; Schormair B; Winkelmann J; Mollenhauer B; Trenkwalder C; Maetzler W; Berg D; Kasten M; Klein C; Höglinger GU; Gasser T; Deuschl G; Franke A; Krawczak M; Dempfle A; Kuhlenbäumer G
    Parkinsonism Relat Disord; 2020 Jun; 75():24-26. PubMed ID: 32442813
    [No Abstract]   [Full Text] [Related]  

  • 6. Diagnostic delay in Parkinson's disease caused by PRKN mutations.
    Ruiz-Lopez M; Freitas ME; Oliveira LM; Munhoz RP; Fox SH; Rohani M; Rogaeva E; Lang AE; Fasano A
    Parkinsonism Relat Disord; 2019 Jun; 63():217-220. PubMed ID: 30692050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence and genetics of Parkinson's disease in sub-Saharan Africans.
    Blanckenberg J; Bardien S; Glanzmann B; Okubadejo NU; Carr JA
    J Neurol Sci; 2013 Dec; 335(1-2):22-5. PubMed ID: 24079843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation analysis of the PARKIN, PINK1, DJ1, and SNCA genes in Turkish early-onset Parkinson's patients and genotype-phenotype correlations.
    Erer S; Egeli U; Zarifoglu M; Tezcan G; Cecener G; Tunca B; Ak S; Demirdogen E; Kenangil G; Kaleagası H; Dogu O; Saka E; Elibol B
    Clin Neurol Neurosurg; 2016 Sep; 148():147-53. PubMed ID: 27455133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parkin-associated Parkinson's disease.
    von Coelln R; Dawson VL; Dawson TM
    Cell Tissue Res; 2004 Oct; 318(1):175-84. PubMed ID: 15503153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of mutations in the PARK2 gene in Serbian patients with Parkinson's disease.
    Jankovic MZ; Dobricic V; Kresojevic N; Markovic V; Petrovic I; Svetel M; Pekmezovic T; Novakovic I; Kostic V
    J Neurol Sci; 2018 Oct; 393():27-30. PubMed ID: 30099245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early-onset Parkinson's disease caused by a novel parkin mutation in a genetic isolate from north-eastern Brazil.
    Chien HF; Rohé CF; Costa MD; Breedveld GJ; Oostra BA; Barbosa ER; Bonifati V
    Neurogenetics; 2006 Mar; 7(1):13-9. PubMed ID: 16328510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial damage-associated inflammation highlights biomarkers in PRKN/PINK1 parkinsonism.
    Borsche M; König IR; Delcambre S; Petrucci S; Balck A; Brüggemann N; Zimprich A; Wasner K; Pereira SL; Avenali M; Deuschle C; Badanjak K; Ghelfi J; Gasser T; Kasten M; Rosenstiel P; Lohmann K; Brockmann K; Valente EM; Youle RJ; Grünewald A; Klein C
    Brain; 2020 Oct; 143(10):3041-3051. PubMed ID: 33029617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease.
    Abbas N; Lücking CB; Ricard S; Dürr A; Bonifati V; De Michele G; Bouley S; Vaughan JR; Gasser T; Marconi R; Broussolle E; Brefel-Courbon C; Harhangi BS; Oostra BA; Fabrizio E; Böhme GA; Pradier L; Wood NW; Filla A; Meco G; Denefle P; Agid Y; Brice A
    Hum Mol Genet; 1999 Apr; 8(4):567-74. PubMed ID: 10072423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of PRKN structural variations identified through whole-genome sequencing.
    Bravo P; Darvish H; Tafakhori A; Azcona LJ; Johari AH; Jamali F; Paisán-Ruiz C
    Mol Genet Genomic Med; 2018 Nov; 6(6):1243-1248. PubMed ID: 30328284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expanding the canvas of PRKN mutations in familial and early-onset Parkinson disease.
    Pandey S; Tomar LR; Kumar S; Dinesh S; Thelma BK
    Parkinsonism Relat Disord; 2019 Sep; 66():216-219. PubMed ID: 31409571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial and autophagic alterations in skin fibroblasts from Parkinson disease patients with Parkin mutations.
    González-Casacuberta I; Juárez-Flores DL; Ezquerra M; Fucho R; Catalán-García M; Guitart-Mampel M; Tobías E; García-Ruiz C; Fernández-Checa JC; Tolosa E; Martí MJ; Grau JM; Fernández-Santiago R; Cardellach F; Morén C; Garrabou G
    Aging (Albany NY); 2019 Jun; 11(11):3750-3767. PubMed ID: 31180333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Digenic parkinsonism: investigation of the synergistic effects of PRKN and LRRK2.
    Dächsel JC; Mata IF; Ross OA; Taylor JP; Lincoln SJ; Hinkle KM; Huerta C; Ribacoba R; Blazquez M; Alvarez V; Farrer MJ
    Neurosci Lett; 2006 Dec; 410(2):80-4. PubMed ID: 17095157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotype-phenotype correlation of Parkinson's disease with PRKN variants.
    Yoshino H; Li Y; Nishioka K; Daida K; Hayashida A; Ishiguro Y; Yamada D; Izawa N; Nishi K; Nishikawa N; Oyama G; Hatano T; Nakamura S; Yoritaka A; Motoi Y; Funayama M; Hattori N;
    Neurobiol Aging; 2022 Jun; 114():117-128. PubMed ID: 35123805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A consanguineous Turkish family with early-onset Parkinson's disease and an exon 4 parkin deletion.
    Dogu O; Johnson J; Hernandez D; Hanson M; Hardy J; Apaydin H; Özekmekçi S; Sevim S; Gwinn-Hardy K; Singleton A
    Mov Disord; 2004 Jul; 19(7):812-816. PubMed ID: 15254940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Two cases of sporadic juvenile Parkinson's disease caused by homozygous deletion of Parkin gene].
    Ujike H; Yamamoto M; Yamaguchi K; Kanzaki A; Takagi M; Kuroda S
    No To Shinkei; 1999 Dec; 51(12):1061-4. PubMed ID: 10654303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.